Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
Cancer Research|September 19, 2007
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?Feyruz V Rassool, Terry J Gaymes, Nader Omidvar, et al.
Oncoimmunology|April 9, 2016
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndromeAstrid Olsnes Kittang, Shahram Kordasti, Kristoffer Evebø Sand, et al.
Nucleic Acids Research|February 11, 2012
A functional assay for microRNA target identification and validationJoop Gäken, Azim M Mohamedali, Jie Jiang, et al.
Cancer|April 8, 2014
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopeniaAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
British Journal of Haematology|March 6, 2008
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphomaWendy Ingram, Stephen Devereux, Emma P Das-Gupta, et al.
Elife|September 5, 2024
Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrowSila Gerlevik, Nogayhan Seymen, Shan Hama, et al.
Cancer Research|August 26, 2010
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcriptionAndrea G S Buggins, Chris Pepper, Piers E M Patten, et al.
Molecular Systems Biology|March 15, 2012
Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entryStephen J Orr, Daniel R Boutz, Rong Wang, et al.
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
British Journal of Haematology|February 9, 2010
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-CPierre Fenaux, Norbert Gattermann, John F Seymour, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Cancer Research|September 19, 2007
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?Feyruz V Rassool, Terry J Gaymes, Nader Omidvar, et al.
Oncoimmunology|April 9, 2016
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndromeAstrid Olsnes Kittang, Shahram Kordasti, Kristoffer Evebø Sand, et al.
Nucleic Acids Research|February 11, 2012
A functional assay for microRNA target identification and validationJoop Gäken, Azim M Mohamedali, Jie Jiang, et al.
Cancer|April 8, 2014
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopeniaAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
British Journal of Haematology|March 6, 2008
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphomaWendy Ingram, Stephen Devereux, Emma P Das-Gupta, et al.
Elife|September 5, 2024
Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrowSila Gerlevik, Nogayhan Seymen, Shan Hama, et al.
Cancer Research|August 26, 2010
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcriptionAndrea G S Buggins, Chris Pepper, Piers E M Patten, et al.
Molecular Systems Biology|March 15, 2012
Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entryStephen J Orr, Daniel R Boutz, Rong Wang, et al.
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
British Journal of Haematology|February 9, 2010
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-CPierre Fenaux, Norbert Gattermann, John F Seymour, et al.
Pageof 23